Antibodies to human leukocyte antigens and eplet patterns associated with platelet transfusion refractoriness in Hispanic patients
References
- Forest SK, Hod EA. Management of the platelet refractory patient. Hematol Oncol Clin North Am 2016;30:665–77. doi:10.1016/j.hoc.2016.01.008.
- Sullivan JC, Pena JR. Use of human leukocyte antigen (HLA)-incompatible platelet units in HLA platelet-refractory patients with limited number of or low-level HLA donor-specific antibodies results in permissive transfusions. Arch Pathol Lab Med 2022;146:1243–51. doi: 10.5858/arpa.2021-0051-OA.
- Liu K, Stephens L, Nedelcu E, Bakhtary S. Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens. Transfusion 2024;64:210–5. doi: 10.1111/trf.17609.
- Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990;75:408–13.
- Couvidou A, Rojas-Jimenez G, Dupuis A, Maitre B. Anti-HLA class I alloantibodies in platelet transfusion refractoriness: from mechanisms and determinants to therapeutic prospects. Front Immunol 2023;14:1125367. doi: 10.3389/fimmu. 2023.1125367.
- Slichter SJ, Davis K, Enright H, et al. Factors affecting post-transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106–14. doi: 10.1182/blood-2003-08-2724.
- Blandin L, Douge A, Fayard A, et al. Platelet transfusion refractoriness and anti-HL A immunization. Transf usion 2021;61:1700–4. doi: https://dx.doi.org/10.1111/trf.16358.
- Deshpande A. The human leukocyte antigen system simplified. Global Journal of Transfusion Medicine 2017;2:77. doi: 10.4103/GJTM.GJTM_45_17.
- Duquesnoy RJ. Update of the HLA class I eplet database in the website based registry of antibody-defined HLA epitopes. Tissue Antigens 2014;83:382–90. doi: 10.1111/tan.12322.
- Farmer HR, Slavish DC, Ruiz J, et al. Racial/ethnic variations in inflammatory markers: exploring the role of sleep duration and sleep efficiency. J Behav Med 2022;45:855–67. doi: 10.1007/s10865-022-00357-8.
- Albert MA, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation 2006;114:e67–74. doi: 10.1161/circulationaha.106.613570.
- Ho RC, Davy KP, Hickey MS, Melby CL. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic White adults. Cytokine 2005;30:14–21. doi: 10.1016/j.cyto.2004.10.015.
- Sosa RA, Terry AQ, Ito T, et al. Immune features of disparate liver transplant outcomes in female Hispanics with non-alcoholic steatohepatitis. Transplant Direct 2023;9:e1550. doi: 10.1097/txd.0000000000001550.
- Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford) 2017;56(Suppl 1):i67–i77. doi: 10.1093/rheumatology/kew399.
- Deng Y, Zhao J, Sakurai D, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet 2013;9:e1003336. doi: 10.1371/journal.pgen.1003336.
- Hurley CK, Kempenich J, Wadsworth K, et al. Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0. HLA 2020;95:516–31. doi: 10.1111/tan.13811.
- Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2010;10:26–9. doi: 10.1111/j.1600-6143.2009.02927.x.
- Dutra VF, Bub CB, Costa TH, et al. Allele and haplotype frequencies of human platelet and leukocyte antigens in platelet donors. Einstein (Sao Paulo) 2019;17:eAO4477. doi: 10.31744/einstein_journal/2019AO4477.
- Kreuger AL, Haasnoot GW, Somers JAE, et al. Ensuring HLA-matched platelet support requires an ethnic diverse donor population. Transfusion 2020;60:940–6. doi: 10.1111/trf.15728.
- Bezstarosti S, Bakker KH, Kramer CSM, et al. A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA Epitope Registry. Front Immunol 2021;12:800946. doi: 10.3389/fimmu.2021.800946.
- Duquesnoy RJ, Marrari M. Usefulness of the ElliPro epitope predictor program in defining the repertoire of HLA-ABC eplets. Hum Immunol 2017;78:481–8. doi: 10.1016/j. humimm.2017.03.005.
- Jaime-Pérez JC, Vázquez-Hernández KE, Jiménez-Castillo RA, Fernández LT, Salazar-Riojas R, Gómez-Almaguer D. Platelet survival in hematology patients assessed by the corrected count increment and other formulas. Am J Clin Pathol 2018;150:267–72. doi: 10.1093/ajcp/aqy052.
- Cohn CS. Platelet transfusion refractoriness: how do I diagnose and manage? Hematology Am Soc Hematol Educ Program 2020;2020:527–32. doi: 10.1182/hematology.2020000137.
- Hosmer DWJ, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken, NJ: Wiley, 2013.
- Boothby AB, Tanner MK, Alswied A, et al. Cumulative donor-specific antibody threshold predicts platelet transfusion response in HL A-alloimmunized patients. Blood Adv 2024;8:4689–99. doi: 10.1182/bloodadvances.2024014143.
- Saito S, Ota S, Seshimo H, et al. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens. Transfusion 2002;42:302–8. doi: 10.1046/j.1537-2995.2002.00051.x.
- Datema G, Stein S, Eijsink C, Mulder A, Claas FH, Doxiadis II. HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody. Vox Sang 2000;79:108–11. doi: 10.1159/000031221.
- Dean CL, Krummey SM, Gebel HM, Bray RA, Sullivan HC. Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing. Hum Immunol 2020;81:73–8. doi: 10.1016/j.humimm.2019.12.006.
- Hilton HG, Parham P. Missing or altered self: human NK cell receptors that recognize HL A-C. Immunogenetics 2017;69:567–79. doi: 10.1007/s00251-017-1001-y.
- Li X, Liu Q, Dong J, et al. Existence and significance of anti-HLA-C autoantibodies to primary and persistent platelet transfusion refractoriness in patients with hematologic disorders: a retrospective study from a single centre. Ann Med 2025;57:2446689. doi: 10.1080/07853890.2024.2446689.
- Oh EJ, Park H, Park KU, Kang ES, Kim HS, Song EY. Interlaboratory comparison of the results of lifecodes LSA class I and class II single antigen kits for human leukocyte antigen antibody detection. Ann Lab Med 2015;35:321–8. doi: 10.3343/alm.2015.35.3.321.
- Sullivan HC, Gebel HM, Bray RA. Understanding solid-phase HLA antibody assays and the value of MFI. Hum Immunol 2017;78:471–80. doi: 10.1016/j.humimm.2017.05.007.
- Ma N, Guo JP, Zhao XY, et al. Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: a prospective study of 3805 subjects. HLA 2022;100:312–24. doi: 10.1111/tan.14704.
- Nambiar A, Duquesnoy RJ, Adams S, et al. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2006;107:1680–7. doi: 10.1182/blood-2004-10-4080.
- Pai SC, Lo SC, Lin Tsai SJ, et al. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases. Transfusion 2010;50:2318–27. doi: 10.1111/j.1537-2995.2010.02703.x.
DOI: https://doi.org/10.2478/immunohematology-2026-015 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 86 - 95
Published online: Oct 11, 2026
Published in print: Sep 1, 2026
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Tiffany R. Wafford, Kevin Burns, Giselle Carnaby, Kelley Hitchman, published by American National Red Cross
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.